Rituxan and Carpal tunnel syndrome - a phase IV clinical study of FDA data

Summary:

Carpal tunnel syndrome is reported as a side effect among people who take Rituxan (rituximab), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Actemra, and have Mouth ulcers.

The phase IV clinical study analyzes which people have Carpal tunnel syndrome when taking Rituxan. It is created by eHealthMe based on reports of 64,282 people who have side effects when taking Rituxan from the FDA, and is updated regularly.

What is Rituxan?

Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 64,791 Rituxan users. Check the latest studies of Rituxan.

What is Carpal tunnel syndrome?

Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling) is found to be associated with 1,120 drugs and 1,264 conditions by eHealthMe. Check the latest studies of Carpal tunnel syndrome.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

64,282 people reported to have side effects when taking Rituxan.
Among them, 178 people (0.28%) have Carpal tunnel syndrome.

Could Rituxan cause Carpal tunnel syndrome?

Among these 178 people:

How long have people been on Rituxan when they have Carpal tunnel syndrome? *

Click here to view more results

What is the gender of people who have Carpal tunnel syndrome when taking Rituxan? *

Click here to view

What is the age of people who have Carpal tunnel syndrome when taking Rituxan? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Rituxan and have Carpal tunnel syndrome?

- Check whether Carpal tunnel syndrome is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rituxan:

Rituxan (64,791 reports)

Carpal tunnel syndrome treatments and more:

Carpal tunnel syndrome (20,689 reports)

How severe was Carpal tunnel syndrome and when was it recovered:

Carpal tunnel syndrome in Rituxan

Expand to all the drugs that have ingredients of rituximab:

Carpal tunnel syndrome and drugs with ingredients of rituximab (311 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rituxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Carpal tunnel syndrome:

Carpal tunnel syndrome (1,120 drugs)

Browse all the conditions that are associated with Carpal tunnel syndrome:

Carpal tunnel syndrome (1,264 conditions)

Related publications that referenced our studies

AbuRagheif MH, "The electrophysiological recording of the carpal tunnel syndrome exaggerated in the hypertensive patients", Iraq Medical Journal, 2017 Oct .
AbuRagheif MH, "The electrophysiological recording of the carpal tunnel syndrome exaggerated in the hypertensive patients", Iraq Medical Journal, 2017 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on rituximab (the active ingredients of Rituxan) and Rituxan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.